Table
4: Relationship
between Bcl-2 mRNA expression levels and EGF doses in the groups.
|
Group |
EGF |
Expression Value (2-∆∆CT) |
25% |
75% |
Pa |
|
C |
0 |
89.99 |
57.71 |
113 |
0.722 |
|
1 |
106.94 |
23.20 |
156 |
||
|
2 |
106.70 |
47.12 |
148.8 |
||
|
3 |
113.38 |
50.35 |
187.1 |
||
|
GU |
0 |
28.05 |
0.82 |
82.56 |
0.253 |
|
1 |
97.77 |
7.07 |
137.2 |
||
|
2 |
98.36 |
30.37 |
147.8 |
||
|
3 |
133.99 |
40.55 |
156.4 |
||
|
DU |
0 |
17.28 |
12.54 |
126.3 |
0.107 |
|
1 |
117.46 |
79.40 |
147.10 |
||
|
2 |
98.53 |
36.60 |
159.5 |
||
|
3 |
130.68 |
74.03 |
160.09 |
||
|
N87 |
0 |
47.83 |
37.10 |
210.5 |
0.169 |
|
1 |
80.44 |
52.40 |
283.6 |
||
|
2 |
39.39 |
25.65 |
81.18 |
||
|
3 |
81.57 |
70.92 |
170.6 |
||
|
Pb |
0 |
0.482 |
|
||
|
1 |
0.798 |
||||
|
2 |
0.331 |
||||
|
3 |
0.532 |
||||